Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Feb 10, 2017 at 8:35 AM EST

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far…

Chris Lange | Feb 9, 2017 at 1:25 PM EST

What Is Driving CVS Revenue Growth?

CVS Health reported mixed fourth-quarter financial results before the markets opened on Thursday.

Chris Lange | Feb 9, 2017 at 10:25 AM EST

Is This the Big Turnaround Acorda Needs?

Shares of Acorda Therapeutics saw a hand gain in early trading on Thursday after the company reported results from its…

Chris Lange | Feb 8, 2017 at 12:35 PM EST

What Analysts Are Saying About Gilead Sciences After Earnings

24/7 Wall St. has included some highlights from the Gilead Sciences earnings report, as well as what analysts are saying…

Chris Lange | Feb 8, 2017 at 11:35 AM EST

Wednesday’s Biggest Biopharma Movers

Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made…

Chris Lange | Feb 7, 2017 at 4:20 PM EST

Why Gilead Earnings Were Not Up to Snuff

Gilead Sciences Inc. (NASDAQ: GILD) reported its fourth-quarter earnings after the markets closed on Tuesday. The company posted $2.70 in…

Chris Lange | Feb 7, 2017 at 12:40 PM EST

Is Teva’s CEO Departure Long Overdue?

Teva Pharmaceutical saw its shares tumble on Tuesday after the company announced a changing of the guard. This CEO departure…

Chris Lange | Feb 7, 2017 at 10:10 AM EST

What to Expect From Gilead Earnings

Gilead Sciences is set to report its fourth-quarter financial results after the markets close on Tuesday.

Paul Ausick | Feb 7, 2017 at 8:20 AM EST

Why Cannabinoid Developer GW Pharma Looks Better Than Ever to Investors

GW Pharmaceuticals, a developer of therapeutics derived from marijuana, reported a smaller than expected loss in its 2017 first quarter.

Chris Lange | Feb 3, 2017 at 1:50 PM EST

Why Neos Therapeutics Shares Are Hitting a New Low

Neos Therapeutics saw its shares sink after the company announced that it had priced its secondary offering of common stock.

Chris Lange | Feb 2, 2017 at 4:43 PM EST

Why Amgen Earnings Are So Incredible

Amgen Inc. (NASDAQ: AMGN) reported its fourth-quarter financial results after the markets closed on Thursday. This biotech giant posted $2.89…

Chris Lange | Feb 2, 2017 at 12:05 PM EST

Why Benitec More Than Doubled

Benitec Biopharma saw its shares more than double on Tuesday after the company gave a business update on its ddRNAi…

Chris Lange | Feb 2, 2017 at 10:40 AM EST

Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results

AMAG Pharmaceuticals shares took a sharp turn down after the company reported top-line results from its most recent pharmacokinetic study.

Chris Lange | Feb 2, 2017 at 9:05 AM EST

Why Merck’s Q4 Earnings Aren’t Enough for Investors

Merck reported disappointing fourth-quarter financial results before the markets opened on Thursday.

Chris Lange | Feb 1, 2017 at 3:11 PM EST

Top 6 Earnings To Watch For On Thursday

Although this earnings season has been relatively positive, the Dow has stepped away from its 20,000 mark, and it seems…

1 … 174 175 176 177 178 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

What Is Driving CVS Revenue Growth?

Is This the Big Turnaround Acorda Needs?

What Analysts Are Saying About Gilead Sciences After Earnings

Wednesday’s Biggest Biopharma Movers

Why Gilead Earnings Were Not Up to Snuff

Is Teva’s CEO Departure Long Overdue?

What to Expect From Gilead Earnings

Why Cannabinoid Developer GW Pharma Looks Better Than Ever to Investors

Why Neos Therapeutics Shares Are Hitting a New Low

Why Amgen Earnings Are So Incredible

Why Benitec More Than Doubled

Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results

Why Merck’s Q4 Earnings Aren’t Enough for Investors

Top 6 Earnings To Watch For On Thursday

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

What Is Driving CVS Revenue Growth?

Is This the Big Turnaround Acorda Needs?

What Analysts Are Saying About Gilead Sciences After Earnings

Wednesday’s Biggest Biopharma Movers

Why Gilead Earnings Were Not Up to Snuff

Is Teva’s CEO Departure Long Overdue?

What to Expect From Gilead Earnings

Why Cannabinoid Developer GW Pharma Looks Better Than Ever to Investors

Why Neos Therapeutics Shares Are Hitting a New Low

Why Amgen Earnings Are So Incredible

Why Benitec More Than Doubled

Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results

Why Merck’s Q4 Earnings Aren’t Enough for Investors

Top 6 Earnings To Watch For On Thursday

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check